Slideshow

Treating Bipolar Depression With Atypical Antipsychotics: Pros, Cons, and Tips

Author(s):

Chris Aiken, MD

Depression predominates across the lifespan in patients with bipolar disorder. Here: A discussion about (and beyond) the four FDA-approved drugs to treat symptoms.

Related Videos
brain depression
brain
Related Content
depression
January 2nd 2025

Navacaprant for Major Depressive Disorder Fails in Late-Stage Study

Leah Kuntz
Blue Light Blockers: A Behavior Therapy for Mania
October 7th 2021

Blue Light Blockers: A Behavior Therapy for Mania

Chris Aiken, MD Kellie Newsome, PMH-NP
renal
December 20th 2024

Demystifying Lithium Therapy—A Primer for Clinicians: Renal Issues, Part 1

Jonathan M. Meyer, MD, DLFAPA
Blue Light, Depression, and Bipolar Disorder
August 4th 2021

Blue Light, Depression, and Bipolar Disorder

Chris Aiken, MD Kellie Newsome, PMH-NP
depression
December 18th 2024

IV Psilocin Benzoate for Major Depressive Disorder: New Phase 2a Results

Leah Kuntz
innovation
December 10th 2024

Psychopharmacology Innovations

John J. Miller, MD
© 2025 MJH Life Sciences

All rights reserved.